Long-Term Safety and Efficacy of Tralokinumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis Treated for up to 6 Years. J of Skin [Internet]. 2025 Mar. 17 [cited 2025 Apr. 19];9(2):s573. Available from: https://skin.dermsquared.com/skin/article/view/3392